股號 / 名稱 | 營收 | 稅後淨利 |
CDTX Cidara Therapeutics Inc | 17,583,000.0 | -5,611,000.0 |
TELA TELA Bio Inc | 16,998,000.0 | -12,890,000.0 |
ADCT ADC Therapeutics SA | 16,790,000.0 | -83,043,000.0 |
NRIX Nurix Therapeutics Inc | 16,585,000.0 | -41,518,000.0 |
THTX Theratechnologies Inc | 16,247,000.0 | -4,481,000.0 |
MXCT MaxCyte Inc | 15,664,600.0 | -5,277,800.0 |
ALEC Alector Inc | 15,190,000.0 | -41,434,000.0 |
GTHX G1 Therapeutics Inc | 14,476,000.0 | -10,219,000.0 |
EYPT EyePoint Pharmaceuticals Inc | 14,028,000.0 | -14,099,000.0 |
ARQT Arcutis Biotherapeutics Inc | 13,526,000.0 | -66,284,000.0 |
TARS Tarsus Pharmaceuticals Inc | 13,076,000.0 | -41,902,000.0 |
RPTX Repare Therapeutics Inc | 13,047,000.0 | -28,030,000.0 |
CAPR Capricor Therapeutics Inc | 12,088,090.0 | -762,090.0 |
BNGO Bionano Genomics Inc | 10,721,000.0 | -43,891,000.0 |
MGNX MacroGenics Inc | 10,720,000.0 | -46,073,000.0 |
MRSN Mersana Therapeutics Inc | 10,701,000.0 | -19,544,000.0 |
TSVT 2Seventy Bio Inc | 10,684,000.0 | -56,822,000.0 |
BFRI Biofrontera Inc | 10,596,000.0 | 3,526,000.0 |
GRTS Gritstone bio Inc | 10,383,000.0 | -30,818,000.0 |
KYMR Kymera Therapeutics Inc | 10,287,000.0 | -48,557,000.0 |
ZYME Zymeworks Inc | 10,030,000.0 | -31,653,000.0 |
EQ Equillium Inc | 9,211,000.0 | -2,342,000.0 |
ABCL Abcellera Biologics Inc | 9,179,000.0 | -47,150,000.0 |
ANAB AnaptysBio Inc | 9,005,000.0 | -42,211,000.0 |
MRUS Merus NV | 8,939,000.0 | -60,153,000.0 |
DBVT Dbv Technologies SA | 8,875,000.0 | -11,186,000.0 |
ENZ Enzo Biochem Inc | 8,553,000.0 | -863,000.0 |
TKNO Alpha Teknova Inc | 7,867,000.0 | -10,656,000.0 |
SBFM Sunshine Biopharma Inc | 7,680,200.0 | -1,250,020.0 |
HOOK HOOKIPA Pharma Inc | 7,407,000.0 | -24,818,000.0 |
ETON Eton Pharmaceuticals Inc | 7,313,000.0 | -2,256,000.0 |
TCRX TScan Therapeutics Inc | 7,211,000.0 | -19,613,000.0 |
DTIL Precision BioSciences Inc | 7,038,000.0 | -13,434,000.0 |
QURE Uniqure NV | 6,689,000.0 | -73,206,000.0 |
CLSD Clearside Biomedical Inc | 6,345,000.0 | -4,832,000.0 |
AADI Aadi Bioscience Inc | 6,326,000.0 | -16,269,000.0 |
SCPH scPharmaceuticals Inc | 6,096,000.0 | -13,812,000.0 |
OCGN Ocugen Inc | 6,036,000.0 | -9,493,000.0 |
TNGX Tango Therapeutics Inc | 5,431,000.0 | -30,763,000.0 |
LQDA Liquidia Corp | 4,531,000.0 | -27,450,000.0 |
SEER Seer Inc | 4,438,000.0 | -17,799,000.0 |
ATRA Atara Biotherapeutics Inc | 4,252,000.0 | -60,450,000.0 |
CLDX Celldex Therapeutics Inc | 4,131,000.0 | -43,306,000.0 |
IDYA IDEAYA Biosciences Inc | 3,922,000.0 | -33,955,000.0 |
IMNM Immunome Inc | 3,826,000.0 | -92,634,000.0 |
CRBU Caribou Biosciences Inc | 3,558,000.0 | -34,505,000.0 |
MESO Mesoblast Ltd | 3,388,000.0 | -32,539,000.0 |
CCCC C4 Therapeutics Inc | 3,261,000.0 | -34,754,000.0 |
TCON TRACON Pharmaceuticals Inc | 3,045,000.0 | 439,000.0 |
CARA Cara Therapeutics Inc | 3,004,000.0 | -32,337,000.0 |
SPRB Spruce Biosciences Inc | 2,887,000.0 | -9,950,000.0 |
STOK Stoke Therapeutics Inc | 2,802,000.0 | -26,958,000.0 |
SYBX Synlogic Inc | 2,769,000.0 | -14,534,000.0 |
CRIS Curis Inc | 2,696,000.0 | -11,712,000.0 |
ALGS Aligos Therapeutics Inc | 2,681,000.0 | -27,892,000.0 |
JANX Janux Therapeutics Inc | 2,461,000.0 | -11,758,000.0 |
THMO Thermogenesis Holdings Inc | 2,406,000.0 | -7,599,000.0 |
KRON Kronos Bio Inc | 2,286,000.0 | -25,320,000.0 |
PULM Pulmatrix Inc | 2,202,000.0 | -2,083,000.0 |
RNA Avidity Biosciences Inc | 2,193,000.0 | -60,443,000.0 |
ABUS Arbutus Biopharma Corp | 2,145,000.0 | -19,312,000.0 |
BOLT Bolt Biotherapeutics Inc | 2,089,000.0 | -17,903,000.0 |
SGMO Sangamo Therapeutics Inc | 2,042,000.0 | -60,295,000.0 |
MGTX MeiraGTx Holdings PLC | 2,040,000.0 | 20,215,000.0 |
XOMA XOMA Corp | 1,833,000.0 | -20,109,000.0 |
CUE Cue Biopharma Inc | 1,821,000.0 | -13,434,000.0 |
DARE Dare Bioscience Inc | 1,807,890.0 | -5,057,560.0 |
OCUP Ocuphire Pharma Inc | 1,691,000.0 | -4,795,000.0 |
FATE Fate Therapeutics Inc | 1,676,000.0 | -44,122,000.0 |
CYTK Cytokinetics Inc | 1,672,000.0 | -136,896,000.0 |
INBX Inhibrx Inc | 1,634,000.0 | -91,970,000.0 |
HOWL Werewolf Therapeutics Inc | 1,501,000.0 | -12,003,000.0 |
INVO INVO Bioscience Inc | 1,381,750.0 | -1,994,780.0 |
HCWB HCW Biologics Inc | 1,324,000.0 | -10,680,530.0 |
PIRS Pieris Pharmaceuticals Inc | 1,299,000.0 | -4,584,000.0 |
PGEN Precigen Inc | 1,228,000.0 | -33,056,000.0 |
LXRX Lexicon Pharmaceuticals Inc | 1,130,000.0 | -48,397,000.0 |
STTK Shattuck Labs Inc | 1,115,000.0 | -18,504,000.0 |
OMGA Omega Therapeutics Inc | 989,000.0 | -20,214,000.0 |
FULC Fulcrum Therapeutics Inc | 871,000.0 | -24,756,000.0 |
VBIV VBI Vaccines Inc | 853,000.0 | -13,000.0 |
LUMO Lumos Pharma Inc | 826,000.0 | -9,457,000.0 |
ADAG Adagene Inc | 815,750.0 | -14,837,560.0 |
DYAI Dyadic International Inc | 686,540.0 | -2,071,800.0 |
PHAT Phathom Pharmaceuticals Inc | 682,000.0 | -79,570,000.0 |
IKNA Ikena Oncology Inc | 659,000.0 | -19,489,000.0 |
SEEL Seelos Therapeutics Inc | 653,000.0 | -5,453,000.0 |
IGMS IGM Biosciences Inc | 651,000.0 | -60,695,000.0 |
EVGN Evogene Ltd | 578,000.0 | -7,337,000.0 |
AQB AquaBounty Technologies Inc | 553,250.0 | -8,424,970.0 |
ENSC Ensysce Biosciences Inc | 515,030.0 | -3,504,360.0 |
PRAX Praxis Precision Medicines Inc | 515,000.0 | -26,878,000.0 |
IOVA Iovance Biotherapeutics Inc | 482,000.0 | -116,379,000.0 |
VTGN Vistagen Therapeutics Inc | 411,400.0 | -6,349,800.0 |
XAIR Beyond Air Inc | 391,000.0 | -17,257,000.0 |
SYRS Syros Pharmaceuticals Inc | 386,000.0 | -64,384,000.0 |
BTAI BioXcel Therapeutics Inc | 376,000.0 | -22,256,000.0 |
LVTX LAVA Therapeutics NV | 353,000.0 | -6,498,000.0 |
ABSI Absci Corp | 338,000.0 | -23,545,000.0 |
PRTA Prothena Corporation PLC | 316,000.0 | -67,476,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰?
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例